1. Scrip
  2. >>Business

A Biopharma A-List Lineup Aims To Tackle Complex Manufacturing At Resilience

 
• By Jessica Merrill

Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.

Dispensing fluid into test tubes
Resilience aims to tackle big manufacturing hurdles • Source: Shutterstock

National Resilience Inc., a new company backed by a rich $800m investment and an impressive leadership pedigree, aims to tackle next-generation biopharma manufacturing challenges, starting in 2021. The company will focus on developing new technologies to manufacture the most complex medicines including cell and gene therapies, viral vectors, vaccines and proteins.

"We are working on technology that is disruptive. It's not just process-development of existing platforms," CEO Rahul Singhvi said in an interview

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Business

Finance Watch: Deerfield Closes $600m-Plus VC Fund; Gates Speeds Up Health Investments

 
• By Mandy Jackson

Private Company Edition: Deerfield’s third innovations fund will back therapeutics and other opportunities, the Gates Foundation – a sometimes funder of biotech firms – will spend $200bn over the next 20 years, and NewLimit raised a $130m series B round, among other financings.

Pharma Left Hanging After US/UK Trade Pact

 
• By Kevin Grogan

An ‘historic economic prosperity deal’ does not include the sector.

Viatris Will File ‘Fast-Acting’ Meloxicam For FDA Approval This Year

 
• By Joseph Haas

Seven years after acquiring it, Viatris will seek approval of a meloxicam formulation for acute pain backed by data from two Phase III studies in post-surgical pain settings.